Literature DB >> 25980471

Renal functional and structural integrity in infants with iron deficiency anemia: relation to oxidative stress and response to iron therapy.

Mohamed S El-Shimi1, Rania A El-Farrash, Eman A Ismail, Ibrahim A El-Safty, A El-Safty, Ahmed S Nada, Omayma A El-Gamel, Yomna M Salem, Sara M Shoukry.   

Abstract

BACKGROUND: Iron deficiency anemia (IDA) is the most common nutritional deficiency in the world. The aim of our study was to evaluate and compare renal functional and structural integrity in 50 infants with IDA and 50 healthy controls and to assess the relation between IDA and oxidative stress and response to iron therapy.
METHODS: This was a prospective study in which peripheral blood samples were collected from all study subjects and the following laboratory investigations performed: serum iron profile, urinary microalbumin, urinary leucine aminopeptidase (LAP), fractional excretion of sodium (FeNa), serum total antioxidant capacity (TAC), serum malondialdehyde (MDA), serum and urinary trace elements (iron, copper, zinc, calcium and magnesium). All patients received oral iron therapy and were followed-up for 3 months.
RESULTS: The levels of baseline urinary markers were higher among the patients with IDA than among the controls (p < 0.05). Patients had a lower pre-therapy TAC and lower serum zinc and magnesium levels than controls as well as higher MDA and serum copper levels (p < 0.05). MDA level was positively correlated to microalbumin and LAP level (p < 0.05). Urinary LAP concentration was positively correlated to urinary trace element concentrations (p < 0.05). A significant decrease in microalbumin, LAP, FeNa, and urinary trace elements was observed post-iron therapy while hemoglobin and ferritin levels were increased (p < 0.05).
CONCLUSION: Among the study subjects, IDA had an adverse influence on renal functional and structural integrity which could be reversed with iron therapy. Oxidative stress played an important role in the pathogenesis of renal injury in IDA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25980471     DOI: 10.1007/s00467-015-3122-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  Evaluation of oxidative status in iron deficiency anemia through total antioxidant capacity measured using an automated method.

Authors:  Mehmet Aslan; Mehmet Horoz; Hakim Çelik
Journal:  Turk J Haematol       Date:  2011-03-05       Impact factor: 1.831

2.  Evaluation of oxidative stress and antioxidant status in pregnant anemic women.

Authors:  Amit Kumar Mani Tiwari; Abbas Ali Mahdi; Fatima Zahra; Sudarshna Chandyan; Vinod Kumar Srivastava; Mahendra P Singh Negi
Journal:  Indian J Clin Biochem       Date:  2010-08-25

3.  Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease.

Authors:  Amanda Crawford; Robert G Fassett; Jeff S Coombes; Dale A Kunde; Kiran D K Ahuja; Iain K Robertson; Madeleine J Ball; Dominic P Geraghty
Journal:  Nephrol Dial Transplant       Date:  2011-02-16       Impact factor: 5.992

4.  Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.

Authors:  Jay L Koyner; Vishal S Vaidya; Michael R Bennett; Qing Ma; Elaine Worcester; Shahab A Akhter; Jai Raman; Valluvan Jeevanandam; Micheal F O'Connor; Prasad Devarajan; Joseph V Bonventre; Patrick T Murray
Journal:  Clin J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 8.237

5.  Malondialdehyde, antioxidant enzymes, and renal tubular functions in children with iron deficiency or iron-deficiency anemia.

Authors:  Demet Altun; Ahmet Emin Kurekci; Orhan Gursel; Duygu Ovunc Hacıhamdioglu; Ismail Kurt; Ahmet Aydın; Okan Ozcan
Journal:  Biol Trace Elem Res       Date:  2014-08-08       Impact factor: 3.738

6.  Reversal of iron deficiency anemia-induced peripheral neuropathy by iron treatment in children with iron deficiency anemia.

Authors:  Nimet Kabakus; Ahmet Ayar; Tahir Kurtulus Yoldas; Hizir Ulvi; Yasar Dogan; Bayram Yilmaz; Nermin Kilic
Journal:  J Trop Pediatr       Date:  2002-08       Impact factor: 1.165

7.  Lipid antioxidants: free radical scavenging versus regulation of enzymatic lipid peroxidation.

Authors:  Alejandro K Samhan-Arias; Yulia Y Tyurina; Valerian E Kagan
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

8.  Iron deficiency anemia: evaluation and management.

Authors:  Matthew W Short; Jason E Domagalski
Journal:  Am Fam Physician       Date:  2013-01-15       Impact factor: 3.292

Review 9.  Physiologic aspects of anemia.

Authors:  Paul C Hébert; Phillipe Van der Linden; George Biro; Ling Qun Hu
Journal:  Crit Care Clin       Date:  2004-04       Impact factor: 3.598

10.  Iron deficiency anemia in infants aged 12-15 months in Ahwaz, Iran.

Authors:  Seyed Mehdi Monajemzadeh; Mohammad Reza Zarkesh
Journal:  Indian J Pathol Microbiol       Date:  2009 Apr-Jun       Impact factor: 0.740

View more
  5 in total

1.  Effect of Oral Iron on Markers of Oxidative Stress and Antioxidant Status in Children with Iron Deficiency Anaemia.

Authors:  Zeeba Zaka-Ur-Rab; Mohammad Adnan; Syed Moiz Ahmad; Najmul Islam
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  End-stage kidney disease in infancy: an educational review.

Authors:  Keia R Sanderson; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2018-11-21       Impact factor: 3.714

Review 3.  Simultaneous management of disordered phosphate and iron homeostasis to correct fibroblast growth factor 23 and associated outcomes in chronic kidney disease.

Authors:  Guillaume Courbon; Marta Martinez-Calle; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-07       Impact factor: 3.416

4.  Alterations in glutathione redox homeostasis among adolescents with obesity and anemia.

Authors:  Dalal Alkazemi; Abdur Rahman; Banan Habra
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

Review 5.  Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology.

Authors:  Ridha I S Alnuwaysir; Martijn F Hoes; Dirk J van Veldhuisen; Peter van der Meer; Niels Grote Beverborg
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.